Skip to content

Abivax

  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • Overview
    • Patients
    • ABX464 for UC
    • ABX464 for Crohn’s
    • ABX464 for RA
    • ABX464 for COVID-19
    • ABX464 for HIV
    • ABX196 for HCC
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Overview
    • Share Price
    • Investor Documents
    • Annual General Meeting
  • Contact Us
Search
  • EN
  • FR
  • DE

News & Events

Press Coverage

  • 2021
  • 2020
  • 2019
  • 2018
  • 2017

LabioTech

January 3, 2017

10 Hot European Biotechs to Observe in 2017

LabioTech

December 10, 2016

These are 10 of the Hottest Biotech Hubs in Europe

Reuters

December 8, 2016

ABIVAX provides update on clinical development program for functional cure of patients with HIV-infection

FierceBiotech

September 15, 2016

Abivax, buoyed by HIV milestone, leads surge in value of biotech stocks in Paris

LabioTech

July 4, 2016

“We have one of the World’s Most Advanced Functional HIV Cures under development”

  • 1
  • …
  • 33
  • 34
  • 35
  • 36
  • 37
© 2021 All rights reserved by ABIVAX | Website created by DIGITAL VALLEE Privacy and Terms of Use
  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • ABX464 for UC
    • ABX464 for HIV
    • ABX196 for HCC
    • ABX544 for Ebola Virus
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Share Profile
    • Share Price
    • Investor Documents
    • Analysts
    • Annual General Meeting
    • UEG Week 2019
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn
  • Follow us on YouTube
  • Follow us on Google+